Skip to content

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration Following Scleral Buckling and Pneumatic Retinopexy.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01843920
Enrollment
21
Registered
2013-05-01
Start date
2011-06-30
Completion date
2013-04-30
Last updated
2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleral Buckling

Keywords

eye, pneumatic retinopexy, topical

Brief summary

A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.

Detailed description

A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration following Scleral Buckling and Pneumatic Retinopexy

Interventions

DRUGTimolol-dorzolamide (Glaucoma drops)

Patients will receive the standard post-operative drops regardless of what group you are in. The glaucoma drops will only be given to the experimental group.

Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim

Sponsors

Jason Hsu, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability to provide written informed consent and comply with study assessments for the full duration of the study. * Have undergone eye surgery including scleral buckling or pneumatic retinopexy for treatment of retinal detachment other condition at the discretion of the investigator.

Exclusion criteria

* Prior surgery to treat glaucoma. * Current use of glaucoma eye drops. * Absence of a lens in the eye or presence of a lens implant in front of the iris (colored part of your eye). * Allergy or contraindication to any of the glaucoma drops being used in this study (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or emphysema), slow heart rate).

Design outcomes

Primary

MeasureTime frameDescription
Complete Resolution of Intraocular Gas BubbleFollowing surgery, until gas bubble is gone. Up to 2 months.This will be reported by the patient when they see/feel the gas bubble disappear.

Secondary

MeasureTime frameDescription
Number of Participants With Return of Intraocular Pressure to Normal LevelsMonth 2Number of participants with a normal intraocular pressure of 10-21 mm Hg at the Month 2 visit

Countries

United States

Participant flow

Participants by arm

ArmCount
Post Surgery Without Glaucoma Drops
This will be for the group that had gas duration surgery using SF6 (Sulfur Hexafluoride) or C3F8 (perfluoropropane gas tamponade) and only uses the standard post-operative topical drops. standard post-operative topical drops: Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim
12
Post Surgery With Glaucoma Drops
This will be for the group that had gas duration surgery (using SF6 or C3F8). In addition to the standard post-operative topical drops, glaucoma drops, Timolol-dorzolamide (timolol 0.5%-dorzolamide 2%) will be given. Timolol-dorzolamide (Glaucoma drops): Patients will receive the standard post-operative drops regardless of what group you are in. The glaucoma drops will only be given to the experimental group. standard post-operative topical drops: Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim
9
Total21

Baseline characteristics

CharacteristicPost Surgery Without Glaucoma DropsPost Surgery With Glaucoma DropsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants2 Participants7 Participants
Age, Categorical
Between 18 and 65 years
7 Participants7 Participants14 Participants
Region of Enrollment
United States
12 participants9 participants21 participants
Sex: Female, Male
Female
5 Participants3 Participants8 Participants
Sex: Female, Male
Male
7 Participants6 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 120 / 9
serious
Total, serious adverse events
0 / 120 / 9

Outcome results

Primary

Complete Resolution of Intraocular Gas Bubble

This will be reported by the patient when they see/feel the gas bubble disappear.

Time frame: Following surgery, until gas bubble is gone. Up to 2 months.

ArmMeasureValue (MEAN)
Post Surgery Without Glaucoma DropsComplete Resolution of Intraocular Gas Bubble40.4 Duration in days, gas bubble
Post Surgery With Glaucoma DropsComplete Resolution of Intraocular Gas Bubble37.8 Duration in days, gas bubble
Secondary

Number of Participants With Return of Intraocular Pressure to Normal Levels

Number of participants with a normal intraocular pressure of 10-21 mm Hg at the Month 2 visit

Time frame: Month 2

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Post Surgery Without Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsHigh IOP at Month 21 Participants
Post Surgery Without Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsNormal IOP at Month 27 Participants
Post Surgery Without Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsLow IOP at Month 21 Participants
Post Surgery Without Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsData Not Available3 Participants
Post Surgery With Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsData Not Available2 Participants
Post Surgery With Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsHigh IOP at Month 20 Participants
Post Surgery With Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsLow IOP at Month 20 Participants
Post Surgery With Glaucoma DropsNumber of Participants With Return of Intraocular Pressure to Normal LevelsNormal IOP at Month 27 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026